Volume 8 Supplement 2

Frontiers of Retrovirology 2011

Open Access

Comparative proteomics of wild-type and nef-deleted HIV-1 particles

  • Christelle Brégnard1, 2,
  • Olivier Danos1, 2, 3 and
  • Stéphane Basmacioqullari1, 2
Retrovirology20118(Suppl 2):P3

https://doi.org/10.1186/1742-4690-8-S2-P3

Published: 3 October 2011

Background

Human and Simian Immunodeficiency viruses acquired auxiliary genes that allowed a better adaptation of viruses to their hosts. Among these genes, nef was shown to play an important role in the onset of immunodeficiency syndromes. Humans infected with viruses harboring major deletions in nef resulting in no Nef expression (Δnef) remain symptom-free for a significantly longer period of time than individuals infected with wild type (WT) viruses. Single round infection assay also reveal that WT viruses are 5-10 fold more infectious than their Δnef counterparts. This phenotype relies on a function of Nef that takes place during viral particles biogenesis. A proteomic analysis of WT and Δnef viruses was conducted to identify differences responsible for the higher infectivity of WT viruses.

Materials and methods

Virions were harvested from cell culture supernatant of 293T cells transfected either with pNL4-3 or pNL4-3 Xho in which the Nef ORF has been disrupted. Supernatants were then ultracentrifuged over two 20 and 60% sucrose cushions. Viral like particles were harvested at the 60-20% interface, diluted in PBS and ultracentrifuged again. Pelleted material was then subjected to Differential Gel Electrophoresis (DIGE) or Isobaric Tagging for Relative and Absolute Quantification (ITRAQ). Proteins enriched either in WT or Δnef virions were selected for further characterization in order to investigate their role in virus infectivity. Candidate proteins were over expressed in WT or Δnef single round infection competent virus-producing cells, alternatively, siRNA was used to silence candidate protein expression.

Results

DIGE and ITRAQ revealed that Nef regulates the incorporation/ exclusion of cellular proteins into/from virions. Both methods showed that Glucosidase II and ERM proteins are enriched in WT and Δnef virions, respectively. In addition, ITRAQ which is more sensitive that DIGE, pointed out other differences, among which CD81, ALG-2 and EHD4, all enriched in Δnef virions, were selected for further characterization, based on their involvement in mechanisms that potentially affect virus biogenesis. Over expression or silencing CD81 in virion-producing cells decreased or increased virus infectivity, respectively. In addition, CD81 decreased virus release. Both effects were observed in HXBc2 env pseudotyped virions, not on VSV-G pseudotyped virions. Silencing Ezrin also increased HXBc2 pseudotyped virus infectivity. Although Ezrin over expression affected neither virus infectivity nor release, over expression of the FERM domain of Ezrin significantly decreased virus release. Glucosidase II, ALG-2 and EHD4 are presently under investigation.

Conclusions

The presence of a different set of cellular proteins in WT and Δnef HIV-1 particles might affect virus infectivity. We clearly demonstrated that Ezrin and CD81 are less abundant in WT virions than in Δnef virions, which correlates with a higher infectivity of WT virions. This could be recapitulated by artificially manipulating the expression level of both proteins in virion producing cells. Interestingly, Nef potently increased the infectivity of virions produced in cells depleted from CD81, or, to lower extent, Ezrin. This suggests a partial overlap between the ability of Nef to exclude CD81/Ezrin from virions in the course of their biogenesis, and to increase virus infectivity.

Authors’ Affiliations

(1)
Hôpital Necker-Enfants Malades, Université Paris Descartes
(2)
INSERM U845, Paris
(3)
Cancer Institute, University College London

Copyright

© Brégnard et al; licensee BioMed Central Ltd. 2011

This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Advertisement